{
    "2018-06-14": [
        [
            {
                "time": "",
                "original_text": "479亿资金争夺20股：主力资金重点出击4股(名单)",
                "features": {
                    "keywords": [
                        "资金",
                        "主力",
                        "股票"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业策略报告：第二家尚未盈利生物医药公司华领医药申请港股IPO",
                "features": {
                    "keywords": [
                        "医药",
                        "IPO",
                        "华领医药"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "14批临床数据自查核查 齐鲁、天晴、石药等成第一梯队",
                "features": {
                    "keywords": [
                        "临床数据",
                        "自查",
                        "齐鲁",
                        "天晴",
                        "石药"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业中期策略：聚焦服务、优质医药、商业三条主线(附股)",
                "features": {
                    "keywords": [
                        "医药",
                        "中期策略",
                        "服务",
                        "优质医药",
                        "商业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业投资策略报告：医保支出结构的改变支持创新药爆发",
                "features": {
                    "keywords": [
                        "医药",
                        "医保",
                        "创新药"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-06-14",
                "original_text": "6月14日券商晨会研报汇编",
                "features": {
                    "keywords": [
                        "券商",
                        "晨会",
                        "研报"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业:关注优先审评受益标的+商业板块",
                "features": {
                    "keywords": [
                        "医药生物",
                        "优先审评",
                        "商业板块"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}